Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Axios on your phone

Get breaking news and scoops on the go with the Axios app.

Download for free.

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Eniola Odetunde/Axios

Fear of the coronavirus and misinformation about the pandemic have created a pool of targets for online scammers.

The big picture: Misinformation around COVID-19 is rampant online, from phony cures to outlandish claims that 5G wireless signals cause the illness. Cybersecurity analysts are also seeing an explosion in phishing and other digital cons that base their scams on these popular coronavirus myths.

What's happening: Researchers at cybersecurity auditor NormShield found a massive uptick in the first three months of 2020 for new domains that make reference to chloroquine and hydroxychloroquine.

  • Those are malaria drugs that President Trump and others have suggested could be an effective treatment for COVID-19, but they have not been proven effective for that use and can have dangerous side effects.
  • The sharpest increase in the new domains came after President Trump first mentioned the drug in a March 19 White House briefing.
  • Many of them hosted phishing websites that purported to be online pharmacies where people could buy the drug, but were actually operations to lift visitors' credit card numbers and other billing and personal information.
  • "Bad actors prey on people's fears, and they prey on people's greed, and in this particular case, they're preying on people's fears," NormShield chief security officer Bob Maley told Axios.

That same dynamic is playing out across a wide range of coronavirus misinformation, said Ryan Kalember, who leads cybersecurity strategy for Proofpoint.

  • He said misinformation that Proofpoint has seen powering scams includes conspiracy theories that either China or the U.S. military developed coronavirus as a bioweapon; overstated claims about hydroxychloroquine and other drugs; and claims that the government has developed a cure or vaccine but is withholding it from the public.

Between the lines: Misinformation about the pandemic and scams related to it are each independently seeing rapid and massive growth.

  • Yonder, an artificial intelligence startup that monitors mis- and disinformation, recently found that it now takes 3 to 14 days for misinformation involving the coronavirus to spread from fringe platforms like 4chan forums to coverage in mainstream press outlets. It typically takes 6 to 8 months for that to happen with other topics, according to Yonder.
  • At the same time, coronavirus scams across the board are exploding, aimed at both individual consumers and institutions like large corporations and health networks. They include phishing emails — often from lookalike domains aping companies, government agencies and public health organizations asking users to give up login or financial information or click on a malware link — as well as phony websites like the fake hydroxychloroquine pharmacies.
  • These cons appear to be conducted by the same actors long responsible for the bulk of online scams around the world, cybersecurity experts told Axios — primarily, practiced operations out of West Africa and Eastern Europe.
  • "There's no new tradecraft," said Kalember. "They're just seeing that coronavirus lures are increasing their click rate like nothing they've ever seen before."

The bottom line: Classic online scams like "Nigerian prince" emails are often rife with misspellings and obvious errors that serve as a kind of natural filter.

  • Cons are more likely to work on people who are gullible enough to ignore such signals and reply to a scam email or blindly click on a phishing link in the first place.
  • Similarly, people who are already falling for coronavirus misinformation make readymade targets for scammers.

Go deeper

Updated 14 mins ago - Sports

Olympics dashboard

🚨: Japan's Naomi Osaka lights Olympic cauldron; Photos

👻: How the no-spectator Olympics could affect the athletes

🇺🇸: "What an honor it is to watch you soar," first lady tells U.S. Olympians

🌏: Meet the underdogs from Latin America

🥇: The six new sports at Tokyo 2020

💉 About 100 U.S. Olympic athletes are unvaccinated

✍️ Axios at the Olympics: What it's like inside the opening ceremony

Go deeper: Full Axios coverage

Senate Democrats demand answers on FBI's Kavanaugh probe

Photographer: Andrew Harrer/Bloomberg via Getty Images

Senate Democrats are demanding that the FBI hand over "all records and communications" related to the FBI tip line set up to investigate Supreme Court Justice Brett Kavanaugh when he was a nominee in 2018.

Why it matters: The ask comes after the FBI revealed it received more than 4,500 tips about Kavanaugh when he was awaiting Senate confirmation amid sexual assault allegations. Only the most "relevant" of these tips were forwarded to the Trump White House.

Chip relief on the horizon

Illustration: Sarah Grillo

Good news: The worst of the chip supply crunch might be near.

The other side: Here's the bad news... CEOs say chips totally flowing like normal is still a ways out.